BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Aigen Investment Management, LP's Holding History (CIK: 0001741224)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 28,058 Value ($000) $219 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 100,403 Value ($000) $762 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 52,805 Value ($000) $473 Avg Close $9.31 Range $6.02 - $11.31
Q3 2024
Shares 28,661 Value ($000) $218 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 16,381 Value ($000) $101 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 41,101 Value ($000) $209 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 12,670 Value ($000) $76 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 153,474 Value ($000) $1,087 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 78,295 Value ($000) $551 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 42,523 Value ($000) $355 Avg Close $9.63 Range $7.82 - $12.08
Q1 2022
Shares 11,172 Value ($000) $182 Avg Close $16.04 Range $11.56 - $19.99
Q1 2021
Shares 21,588 Value ($000) $220 Avg Close $10.31 Range $7.27 - $14.24
Q2 2020
Shares 13,984 Value ($000) $67 Avg Close $3.99 Range $1.80 - $6.29